Development and validation of deep learning for predicting the growth of ovarian cancer organoids
{{output}}
Background: Organoids have attracted enormous interest in disease modeling, drug screening, and precision medicine. However, developing robust patient-derived organoids (PDOs) was time-consuming, costly, and had low success rates... ...
